2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
复制标题

DOI:
10.1016/j.joa.2015.12.001
复制
发表时间:
2016-02
影响因子:
2
通讯作者:
Zhang S
Zhang S
中科院分区:
其他
文献类型:
--
作者:
Wilkoff BL;Fauchier L;Stiles MK;Morillo CA;Al-Khatib SM;Almendral J;Aguinaga L;Berger RD;Cuesta A;Daubert JP;Dubner S;Ellenbogen KA;Estes NA 3rd;Fenelon G;Garcia FC;Gasparini M;Haines DE;Healey JS;Hurtwitz JL;Keegan R;Kolb C;Kuck KH;Marinskis G;Martinelli M;McGuire M;Molina LG;Okumura K;Proclemer A;Russo AM;Singh JP;Swerdlow CD;Teo WS;Uribe W;Viskin S;Wang CC;Zhang S

文献摘要

被引文献

相似文献

植入式心律转复除颤器(ICD)治疗显然是可定义人群中选定患者的有效治疗。ICD治疗的受益和风险直接受到程控和手术决策的影响。这种灵活性既是一个巨大的优势,也是一个弱点,对此事先没有进行正式讨论或指导。四大洲电生理学会一致认为,有四个重要的临床问题,有足够的ICD临床和试验数据提供循证专家指导。本文系统地介绍了。80%(83- 100%,平均值:96%)要求通过正式投票就(i)心动过缓模式和频率、(ii)心动过速检测、(iii)心动过速治疗和(iv)除颤有效性的术中测试的程控达成共识。心律协会(HRS)、欧洲心律协会(EHRA)、亚太心律协会(APHRS)和
Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected patients in definable populations. The benefits and risks of ICD therapy are directly impacted by programming and surgical decisions. This flexibility is both a great strength and a weakness, for which there has been no prior official discussion or guidance. It is the consensus of the four continental electrophysiology societies that there are four important clinical issues for which there are sufficient ICD clinical and trial data to provide evidence-based expert guidance. This document systematically describes the. 80%(83–100%, mean: 96%) required consensus achieved for each recommendation by official balloting in regard to the programming of (i) bradycardia mode and rate,(ii) tachycardia detection,(iii) tachycardia therapy, and (iv) the intraprocedural testing of defibrillation efficacy. Representatives nominated by the Heart Rhythm Society (HRS), European Heart Rhythm Association (EHRA), Asian Pacific Heart Rhythm Society (APHRS), and the